Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
The Journal of Infectious Diseases|June 6, 2019
Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US InfantsEric A F Simões, Viktor Chirikov, Marc Botteman, et al.Plos One|May 27, 2015
Antenatal syphilis screening using point-of-care testing in low- and middle-income countries in Asia and Latin America: a cost-effectiveness analysisAndreas Kuznik, Christine Muhumuza, Henry Komakech, et al.Journal of Managed Care & Specialty Pharmacy|June 29, 2018
Intravitreal Aflibercept Versus Ranibizumab for Wet Age-Related Macular Degeneration: A Cost-Effectiveness AnalysisLuis Hernandez, Tereza Lanitis, Clifford Cele, et al.International Journal of Antimicrobial Agents|October 26, 2007
Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infectionsHelio S Sader, Rajiv Mallick, Andreas Kuznik, et al.Plos Neglected Tropical Diseases|January 9, 2015
Cost-effectiveness of antivenoms for snakebite envenoming in NigeriaAbdulrazaq G Habib, Mohammed Lamorde, Mahmood M Dalhat, et al.Advances in Therapy|October 18, 2017
Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USABenjamin Chastek, Chieh-I Chen, Clare Proudfoot, et al.Ophthalmology and Therapy|September 19, 2025
Economic Benefit of Aflibercept 8 mg Versus Faricimab for Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the USAndreas Kuznik, Anna Coughlan, Amy Pinsent, et al.American Journal of Therapeutics|August 31, 2010
Cardiovascular and economic outcomes after initiation of atorvastatin versus simvastatin in an employed population stratified by cardiovascular riskRoss J Simpson, James Signorovitch, Karthik Ramakrishnan, et al.The Journal of Infectious Diseases|April 16, 2019
Economic-Burden Trajectories in Commercially Insured US Infants With Respiratory Syncytial Virus InfectionViktor V Chirikov, Eric A F Simões, Andreas Kuznik, et al.Infection Control and Hospital Epidemiology|January 9, 2008
Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infectionsJohn Edelsberg, Ariel Berger, David J Weber, et al.Pageof 8